Kinnate Biopharma
KNTE
$2.65
Share price
0.00%
Change (1 day)
-38.37%
Change (1 year)
Categories
Kinnate Biopharma (KNTE) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $14.27 M
According to Kinnate Biopharma's latest financial reports the company's total liabilities are $14.27 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Kinnate Biopharma - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $20.35 M | 64.35% |
| 2021-12-31 | $12.38 M | 69.59% |
| 2020-12-31 | $7.3 M | -92.32% |
| 2019-12-31 | $95.09 M | 20262.1% |
| 2018-12-31 | $0.46 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $22.14 M | 55.07% | 🇺🇸 USA |